Pamela Stephenson
Net worth: 1 M $ as of 2026-08-30
Net worth: 1 M $ as of 2026-08-30
Ms. Pamela Stephenson is a Chief Commercial Officer at Disc Medicine, Inc. Ms. Stephenson was previously employed as a Chief Commercial Officer by Albireo Pharma, Inc., an Independent Director by Zynerba Pharmaceuticals, Inc., and a Vice President-Global Market Access & Value by Vertex Pharmaceuticals, Inc. She received her undergraduate degree from Brown University and a graduate degree from Boston University School of Public Health.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DISC MEDICINE, INC. 0.05% | 2026-04-21 | 18,665 ( 0.05% ) | 1 M $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| DISC MEDICINE, INC. | Corporate Officer/Principal | 2024-02-25 |
| Companies | Position | End |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Director/Board Member | 2023-10-09 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 2023-03-31 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2019-02-28 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Public Health
Boston University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions